Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,371 | 31,167 | 73,981 | 50,708 | 71,722 |
| Marketable Securities | 22,406 | 73,944 | 22,518 | 106,513 | 149,680 |
| Receivables | 34,097 | 12,103 | N/A | N/A | N/A |
| Inventories | 20,298 | 10,380 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 2,248 | 2,443 | 3,326 |
| TOTAL | $134,208 | $134,202 | $100,843 | $192,490 | $263,454 |
| Non-Current Assets | |||||
| PPE Net | 453 | 585 | 839 | 285 | 359 |
| Intangibles | 16,836 | 16,836 | 16,836 | 16,836 | 16,836 |
| Other Non-Current Assets | 12,739 | 13,075 | 14,267 | 37,654 | 30,988 |
| TOTAL | $30,028 | $30,496 | $31,942 | $54,775 | $48,183 |
| Total Assets | $164,236 | $164,698 | $132,785 | $247,265 | $311,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 37,668 | N/A | N/A |
| Accounts payable and accrued liabilities | 7,328 | 11,433 | 7,890 | 7,679 | 2,934 |
| Accrued Expenses | 40,651 | 24,227 | 7,334 | 7,151 | 6,501 |
| Other current liabilities | 273 | 261 | 1,941 | 5,270 | 5,200 |
| TOTAL | $48,834 | $36,855 | $55,793 | $21,000 | $15,109 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 91,614 | 142,397 | 128,210 |
| Other Non-Current Liabilities | 41,554 | 40,104 | 6,523 | 5,624 | 6,052 |
| TOTAL | $41,554 | $40,104 | $98,137 | $148,021 | $134,262 |
| Total Liabilities | $90,388 | $76,959 | $153,930 | $169,021 | $149,371 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,629 | 90,577 | 64,478 | 59,032 | 58,465 |
| Common Shares | 965 | 898 | 628 | 586 | 583 |
| Retained earnings | -794,328 | -745,496 | -585,220 | -447,756 | -384,187 |
| Other shareholders' equity | -24,580 | -23,167 | -26,341 | -23,940 | -21,051 |
| TOTAL | $73,848 | $87,739 | $-21,145 | $78,244 | $162,266 |
| Total Liabilities And Equity | $164,236 | $164,698 | $132,785 | $247,265 | $311,637 |